The primary mission of APS ACTION is to prevent, treat, and cure antiphospholipid antibody (aPL) associated clinical manifestations through high-quality, multicenter, and multidisciplinary clinical research. Their secondary mission is to refine and advance the definitions of aPL associated clinical manifestations through international collaboration and data sharing.
Their approach is simple: Members will work together to create a research alliance that will design and conduct clinical trials, and collect data via an international registry.
For more information, visit apsaction.org.